Today the UK government repeated the same exhausted script on electromagnetic hypersensitivity: the symptoms are real, the suffering may be disabling, but the public must not connect that suffering to electromagnetic fields. UKHSA leans on WHO, SCHEER, and AGNIR, then repeats WHO’s old line that EHS has “no clear diagnostic criteria” and “no scientific basis” to link symptoms to EMF exposure.
That is not humility. That is institutional denial dressed up as compassion.
A lack of diagnostic criteria is not proof of absence. It is proof that regulators have not built the right diagnostic framework. In every other area of modern medicine, when crude tests fail to capture complex biology, we improve the tests. We stratify patients. We look at genetics, physiology, timing, dose, exposure pattern, comorbid state, sleep, autonomic function, inflammation, and delayed response windows.
But with EHS, the official machine does the opposite. It takes the failure of narrow provocation studies—“can this person consciously detect when the signal is on?”—and converts that into a sweeping denial of biological effect.
That is the central fraud in the EHS debate.
Humans are not dosimeters. Humans are not perfect RF meters. A person can fail to consciously detect a signal and still have a measurable physiological response. Sleep EEG, calcium-channel timing, mitochondrial redox state, autonomic tone, immune signaling, gene-expression timing, and symptom cascades do not require conscious perception.
The real question is not whether every self-identified EHS patient can feel every router in real time. The real question is whether a biologically definable subgroup has a vulnerable receiver state that responds to specific electromagnetic waveforms. That is the question WHO and UKHSA should be asking. Instead, they are recycling a 2005 conclusion into a 2026 world.
And that is exactly why President Donald Trump’s withdrawal from WHO matters.
The official U.S. rationale for withdrawal was not EHS. It was WHO’s COVID-19 failures, its refusal to implement reforms, its lack of accountability, transparency, and independence, and the disproportionate financial burden carried by American taxpayers. HHS states that President Trump signed Executive Order 14155 on January 20, 2025, and that the United States formally exited WHO on January 22, 2026.
But the EHS statement shows the same institutional disease in another domain: global health bodies speaking with political certainty where the science demands precision, humility, and open investigation.
The UK should not be proud of aligning itself with that. It should be embarrassed.
The modern evidence does not support the old cartoon version of EHS as “people claiming to be Wi-Fi detectors.” The modern evidence points toward a much more serious question: genotype-dependent, state-dependent, waveform-dependent biological susceptibility.
A 2025 randomized, double-blind, sham-controlled NeuroImage study found that 3.6 GHz 5G RF-EMF modulated NREM sleep-spindle center frequency in a CACNA1C genotype-dependent manner. CACNA1C encodes the alpha-1C subunit of the L-type voltage-gated calcium channel. That does not prove EHS. It does not prove harm. But it does prove that a defined RF exposure can shift an objective human brain rhythm differently depending on genotype.
That is the doorway regulators keep pretending does not exist.
A 2024 Sleep Medicine study found that a CACNA1C variant was associated with both reduced subjective sleep quality and self-reported EMF sensitivity, while appropriately noting that this does not prove causation. Again, this is not the end of the inquiry. It is the beginning of the inquiry.
Then look at the mechanistic field. A 2026 Cell paper reported an electromagnetic-field-inducible gene switch and identified Cyb5b through CRISPR-Cas9 screening as an essential mediator, with calcium oscillations central to the mechanism. That does not make CYB5B an EHS biomarker. But it makes a mockery of the claim that EMF-to-calcium-to-gene-expression biology is unthinkable.
Look at TheraBionic P1. FDA describes it as a handheld radiofrequency electromagnetic-field generator that emits specific amplitude-modulated frequencies, with EMF frequencies that may stop cancer cells from dividing. The FDA-authorized humanitarian-device record also says patients receiving calcium-channel blockers should not use it unless treatment is modified, and the FDA summary cites work on tumor-specific amplitude-modulated RF-EMF targeting CaV3.2 T-type voltage-gated calcium channels and calcium influx.
That is the contradiction regulators do not want to discuss. In one room, they tell the public that non-ionizing RF biology below heating thresholds is not a serious regulatory concern. In another room, they authorize a medical device using amplitude-modulated RF fields in a cancer context and flag calcium-channel blockers as relevant.
You cannot have it both ways.
The FCC cannot hide behind the old thermal model either. In 2021, the D.C. Circuit remanded the FCC’s decision to keep its 1996 RF exposure limits unchanged because the agency failed to provide a reasoned explanation for why its guidelines adequately protect against harmful effects unrelated to cancer. The court specifically required the FCC to address children, long-term exposure, pulsation or modulation, technological developments since 1996, ubiquity of wireless devices, and environmental impacts.
That is not a fringe talking point. That is a federal court telling the FCC: you did not do your job.
NTP’s own public record is also not compatible with lazy dismissal. NTP reported clear evidence of an association between high exposure to cell-phone RFR and malignant schwannomas of the heart in male rats, some evidence for malignant gliomas, and RFR-associated DNA damage in specific tissues. NTP also says the studies were designed to test whether RFR could cause biological effects at exposure levels that did not significantly raise body temperature.
Then came the 2026 Environmental Health paper by Ronald Melnick and Joel M. Moskowitz. Using experimental animal data and standard risk-assessment methods, they concluded that current public RF-EMF regulatory limits are 15- to 900-fold higher than their cancer-risk estimates, depending on daily exposure duration, and 8- to 24-fold higher than levels protective of male reproductive health.
That is the context UKHSA leaves out when it tells the public that symptoms are “not directly related” to EMFs.
The UK guidance also says central to UKHSA advice is compliance with ICNIRP guidelines, and that public exposures are typically well below those guidelines. But “below ICNIRP” is not a synonym for “safe” if the underlying model is too narrow, too thermal, too short-term, and too insensitive to chronic, pulsed, modulated, developmental, neurological, reproductive, and genotype-dependent effects.
That is the capture problem. Whether one calls it regulatory capture, institutional inertia, ICNIRP groupthink, or industry-compatible blindness, the result is the same: suffering people are told their symptoms are real, while the environmental variable they report is dismissed before the right biological tests have even been run.
The better scientific position is simple:
EHS should not be treated as a completed diagnosis.
EHS should not be treated as a superstition.
EHS should be treated as an unresolved precision-physiology problem.
The next generation of studies should not ask whether people are perfect wireless meters. They are not. The next generation of studies should ask whether defined subgroups show objective active-versus-sham physiological changes under properly blinded, genotype-stratified, state-modeled conditions.
That means whole-genome sequencing. CACNA1C, CACNA1H, CACNA1F, CYB5B, voltage-gated ion-channel genes, mitochondrial-redox genes, circadian genes, and non-coding regulatory variants. It means high-density sleep EEG. It means NREM spindle center frequency. It means HRV, microarousals, pupillometry, skin conductance, blood pressure, delayed symptom windows, personal RF/ELF dosimetry, mitochondrial assays, calcium-waveform analysis, redox markers, and patient-derived cells.
That is how real science moves forward.
The UK government should retract this lazy guidance and replace it with a serious research agenda. It should stop outsourcing public health judgment to WHO and ICNIRP. It should create low-EMF medical accommodations for people who are suffering now. It should fund genotype-stratified EHS studies. It should require wired and fiber-first infrastructure in schools, hospitals, housing, and public buildings. It should accelerate Li-Fi and optical wireless systems for indoor high-duty data where pulsed RF is not necessary.
And yes, if the UK were smart, it would follow Trump’s lead and withdraw from WHO—or at minimum stop treating WHO as an infallible oracle.
America should finish the job too. Return RF health guidance to the EPA. Repeal Section 704, the federal gag rule that prevents local governments from regulating wireless facility placement on the basis of RF environmental effects when facilities comply with FCC rules. Enforce Public Law 90-602 through the electronic product radiation-control provisions now codified in federal law, including the duty to minimize unnecessary electronic product radiation exposure. Complete the FCC remand. Replace thermal-only compliance theater with modern health-protective engineering.
This is not anti-technology. This is pro-biology.
We do not need to choose between connectivity and children. We do not need to choose between progress and people with EHS. Fiber exists. Wired defaults exist. Li-Fi exists. Better engineering exists.
The old microwave age was built on the assumption that if it does not cook you, it cannot harm you.
That assumption is dead.
The future is not more denial from WHO. The future is mechanism, mitigation, and protection. The future is biological fidelity. The future is clean communications infrastructure.
The UK can keep repeating a failed global script, or it can lead.
But it cannot keep telling suffering people that their symptoms are real while refusing to build the science capable of finding out why.
